Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1Gastrointestinal 1Classical hematology 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Lymphoma, Non-Hodgkin 1Fanconi Anemia 1Colorectal Neoplasms 1Anus Neoplasms 1

Interventions

Fluorouracil 8Radiotherapy 4Mitomycin 4Cyclophosphamide 3Cisplatin 3pembrolizumab 2fludarabine phosphate 2fludarabine 2aldesleukin 2Watchful Waiting 2VGX-3100 2Specimen Handling 2Papillomavirus Vaccines 2Nivolumab 2Magnetic Resonance Spectroscopy 2Light Coagulation 2Ipilimumab 2Cetuximab 2CTLA-4 Antigen 2Biopsy 2tempol 1rocakinogene sifuplasmid 1enzalutamide 1durvalumab 1dehydroftorafur 1alovudine 1abiraterone 1Yoga 1Therapeutics 1SRA737 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Anus Neoplasms × SRA737 × Clear all
NCT02797964 2023-06-18

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Sierra Oncology LLC - a GSK company

Phase 1/2 Completed
107 enrolled 20 charts
Classical hematologyGastrointestinalHead & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Fanconi Anemia, Lymphoma, Non-Hodgkin, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡